期刊
CHEMICAL RECORD
卷 15, 期 3, 页码 616-635出版社
WILEY-V C H VERLAG GMBH
DOI: 10.1002/tcr.201402100
关键词
boron; boronic acids; carboranes; drug design; inhibitors
资金
- Grants-in-Aid for Scientific Research [26293007, 26102721] Funding Source: KAKEN
The use of the element boron, which is not generally observed in a living body, possesses a high potential for the discovery of new biological activity in pharmaceutical drug design. In this account, we describe our recent developments in boron-based drug design, including boronic acid containing protein tyrosine kinase inhibitors, proteasome inhibitors, and tubulin polymerization inhibitors, and ortho-carborane-containing proteasome activators, hypoxia-inducible factor 1 inhibitors, and topoisomerase inhibitors. Furthermore, we applied a closo-dodecaborate as a water-soluble moiety as well as a boron-10 source for the design of boron carriers in boron neutron capture therapy, such as boronated porphyrins and boron lipids for a liposomal boron delivery system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据